Custom Manufacturing Industry podcast is an entrepreneurship and motivational podcast on all platforms, hosted by Aaron Clippinger. Being CEO of multiple companies including the signage industry and the software industry, Aaron has over 20 years of consulting and business management. His software has grown internationally and with over a billion dollars annually going through the software. Using his Accounting degree, Aaron will be talking about his organizational ways to get things done. Hi ...
…
continue reading
Player FM - Internet Radio Done Right
Checked 14h ago
เพิ่มแล้วเมื่อ threeปีที่ผ่านมา
เนื้อหาจัดทำโดย Tom Froggatt เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Tom Froggatt หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Player FM - แอป Podcast
ออฟไลน์ด้วยแอป Player FM !
ออฟไลน์ด้วยแอป Player FM !
Careers in Discovery
ทำเครื่องหมายทั้งหมดว่า (ยังไม่ได้)เล่น…
Manage series 3141589
เนื้อหาจัดทำโดย Tom Froggatt เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Tom Froggatt หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
…
continue reading
100 ตอน
ทำเครื่องหมายทั้งหมดว่า (ยังไม่ได้)เล่น…
Manage series 3141589
เนื้อหาจัดทำโดย Tom Froggatt เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Tom Froggatt หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
…
continue reading
100 ตอน
ทุกตอน
×On this episode of Careers in Discovery, we spoke with Riccardo Panella, Founder and Chief Scientific Officer of Resalis Therapeutics, and Associate Professor at the Center of RNA Medicine in Copenhagen. Riccardo shared his journey from academia to Biotech entrepreneurship, discussing how a serendipitous discovery during his postdoctoral research at Harvard led him to explore the role of microRNAs in metabolism. He delved into the challenges and rewards of founding Resalis Therapeutics, highlighting the importance of resilience in securing funding and the differences between academic and commercial science. We also explored his perspectives on leadership, the value of collaboration, and the advice he would give to early-career scientists. A compelling conversation about adaptability, perseverance, and the pursuit of translational science.…
This week on Careers in Discovery , we sat down with Kathryn Penkus Corzo, President & COO of bit.bio, to talk about her journey from clinical pharmacy to leading a company at the forefront of cell therapy and drug discovery. Kathryn shared how bit.bio is using machine learning and cell coding to create scalable, precision-engineered human cells - both for research and as potential therapies. She also reflected on her career path, from cold calling her way into Roche in Switzerland to leadership roles at Lilly, Sanofi, and Takeda, and why taking risks, embracing change, and working internationally shaped her success. We also talked about culture, mentorship, and knowing when to push yourself - and why stepping outside your comfort zone is the key to real growth. A great conversation with a leader who’s driving the future of cell therapy.…
This week on Careers in Discovery , we spoke with Graham Dempsey, CSO of Quiver Bioscience, to talk about his journey from a passion for sports medicine to leading a company at the cutting edge of neuroscience drug discovery. Graham shared how Quiver is combining stem cell models, optogenetics, and AI to study brain diseases at an unprecedented scale, and what he’s learned from spending over a decade growing within the same company, from Senior Scientist to CSO. We also explored the realities of Biotech growth, the challenges of translating research into real-world impact, and why persistence is key to success in this space. A fascinating insight into the future of brain-targeted drug development.…
This week on Careers in Discovery , we sat down with Marco Schmidt, CSO of biotx.ai, to talk about AI, Biotech, and the future of drug discovery. Marco’s career has taken him from Biochemistry to Biotech start-ups, where he’s using causal inference to reshape clinical trials and drug development. We explored the evolution of AI in science, the rise of tech-bio companies, and why he believes this is the best time in history to be a scientist. We also got into the mindset shift needed for scientists moving into business - and why failure isn’t just inevitable, but essential. Join us for a really thought-provoking episode.…
This week on Careers in Discovery , we’re joined by Tommi Kainu, Chairman of GlyProVac, a Biotech developing bacterial vaccines with the potential to tackle antimicrobial resistance. Tommi’s career has taken him from medicine and research to consulting at BCG and leadership roles in Biotech. He shared insights on GlyProVac’s work, why commercial thinking is key in drug development, and lessons from his time at Bavarian Nordic - including the unexpected rise of the MPOX vaccine. His advice for scientists moving into industry? Start with the end in mind. A great conversation on science, strategy, and the business of Biotech.…
This week, Emma spoke with Martijn Van De Bunt, Chief Scientific Officer at Cytoki Pharma, a pioneering Biotech in Denmark developing IL-22-based therapies for obesity, type 2 diabetes, and inflammatory bowel disease. Martijn shared insights from his journey from medicine and academia to leading a lean, globally connected Biotech team advancing transformative therapies. Martijn discussed the pivotal moments in his career, from a PhD at Oxford that sparked his passion for impactful science, to his tenure at Novo Nordisk, and ultimately to joining Cytoki Pharma. Along the way, he emphasised the importance of adaptability, the nuances of transitioning between academia and industry, and the role of networks and teamwork in achieving success. With Cytoki Pharma approaching critical milestones in their clinical studies, Martijn also reflected on the challenges and excitement of developing ground-breaking treatments in a dynamic Biotech environment. Tune in for a conversation packed with advice on career growth, the evolution of drug discovery, and the human side of building innovative Biotech companies.…
This week, we welcomed Jordi Carreras-Puigvert, Chief Scientific Officer and Co-Founder of Phenaros, a Swedish company revolutionising drug discovery at the intersection of artificial intelligence and life sciences. Jordi shared his journey from personal tragedy inspiring a career in science, to leading a cutting-edge platform combining high-content microscopy and AI to accelerate therapeutic development, especially in rare diseases. Jordi delved into his unconventional career path, including his foundational work in phenotypic drug discovery, insights on transitioning from academia to biotech, and the critical role of mentorship and networking in shaping his success. He also explored the transformative potential of AI in drug development, emphasising the importance of generating high-quality data to drive innovation. Listen in for a brilliant conversation about leveraging technology to address unmet medical needs, and the power of adaptability in forging a meaningful career in science.…
In this episode of Careers in Discovery , Emma sits down with Henri Huttunen, Chief Scientific Officer at Herantis Pharma, a Finnish biotech developing ground-breaking therapies for Parkinson’s and related neurodegenerative diseases. Henri shares the exciting progress on their next-generation molecule that crosses the blood-brain barrier and their innovative approach to tackling the challenges of clinical trials in this field. Henri reflects on his journey, from his early days in academic research to founding start-ups and leading Herantis’ mission to develop disease-modifying treatments. He talks about the importance of balancing scientific rigour with innovation, navigating the risks of challenging established dogmas, and the role personal passion plays in driving success. This episode is packed with insights into the cutting edge of neurodegenerative research, the lessons learned from taking bold career steps, and the inspiration behind Henri’s dedication to improving patients’ lives. Tune in for an inspiring and thought-provoking conversation.…
In this episode of Careers in Discovery , Emma is joined by Arvid Söderhall, the first employee and project lead at Empros Pharma, as he shares his unique journey from physicist to biotech innovator. Arvid unveils the vision behind Empros Pharma’s pioneering work to combat obesity with a pharmaceutical approach to gastric bypass surgery. Emma and Arvid’s conversation delves into the evolution of Empros Pharma, the challenges of developing innovative treatments in a competitive field, and the critical importance of adapting to an ever-changing market landscape. Arvid also reflects on his career trajectory, discovering his leadership potential, and the value of seizing unexpected opportunities along the way. A must-listen episode for biotech enthusiasts, aspiring leaders, and anyone passionate about making an impact in the life sciences industry.…
This week on Careers in Discovery , we’re joined by Jonas Dyhrfjeld-Johnsen, Chief Development Officer and Managing Director at Acousia Therapeutics, a company developing innovative therapies to preserve and restore hearing. Jonas shares his journey from academic Biophysics to Biotech leadership, reflecting on the importance of adaptability and continuous learning. We discuss Acousia’s groundbreaking work targeting sensory hair cells and their Phase 2 trial aimed at preventing chemotherapy-induced hearing loss, as well as the challenges and rewards of leading a lean, virtual Biotech. An inspiring conversation about tackling a major global health issue and building a meaningful career in science.…
Could microglia hold the key to treating neurodegenerative diseases? This week on Careers in Discovery , Emma Hobbs is with David Gray, Chief Scientific Officer at Vigil Neuroscience, who is pioneering new approaches to harness the brain’s immune system. David shares his unique career journey, from aspiring author to leading drug discovery programs at Pfizer and now in Biotech. He reflects on the power of curiosity, mentorship, and cross-disciplinary learning that shaped his path to leadership. In this episode, David and Emma discuss Vigil's ground-breaking work in targeting ALSP and Alzheimer’s disease, the lessons he’s learned transitioning from big pharma to Biotech, and why having fun is essential to building a fulfilling scientific career. Join us for an inspiring conversation about leadership, innovation, and advancing treatments for patients in need.…
This week on Careers in Discovery, we’re joined by Rodrigo Santos, CTO of clock.bio, a company pushing the boundaries of cellular rejuvenation to tackle age-related diseases. Rodrigo shares the fascinating work happening at clock.bio, including their hypothesis-free approach to uncovering rejuvenation factors and the creation of their “Atlas of Rejuvenation Factors.” We also got to hear about Rodrigo’s incredible journey - from growing up in a small farming village in Portugal to leading cutting-edge biotech companies - all driven by his passion for cellular plasticity and the transformative potential of Yamanaka factors. Along the way, he reflects on the lessons he’s learned, balancing science and business, and why emphasis on execution is key. Join us as we explore the science of rejuvenation, the innovation behind it, and the mindset needed to succeed in this ever-evolving field.…
In this episode of Careers in Discovery , we had the pleasure of talking to Jen Fortune, Chief Operating Officer at Precede Biosciences. Jen shared her fascinating journey, from a PhD in chemistry to consulting, big pharma, and now driving operations in a cutting-edge liquid biopsy company. Her story is one of curiosity, grit, and seizing opportunities alongside incredible people. We also explored the game-changing potential of Precede’s work in epigenomics and how their innovative platform is helping to unlock the future of precision medicine. Along the way, Jen reflects on her passion for mentoring, the importance of fostering diversity, and how embracing your authentic style can drive both personal and professional success. This is a conversation full of practical insights and inspiration for anyone navigating a career in science, leadership, or the life sciences industry.…
In this episode of Careers in Discovery , we’re with James Field, the founder and CEO of LabGenius, as we discuss his remarkable journey from PhD student to biotech entrepreneur. James reveals the vision behind LabGenius, a company harnessing the power of machine learning and protein engineering to transform therapeutic antibody discovery. Our conversation explores the challenges of early-stage entrepreneurship, the importance of surrounding yourself with the right people, and the transition from being a scientist at the bench to leading a multidisciplinary team. James also reflects on the role of focus, perseverance, and tackling unsolved problems in building a world-class biotech organisation. A must-listen episode for aspiring founders, scientists, and anyone curious about the intersection of AI and biology.…
This week on Careers in Discovery we’re with Katie Binley, CSO of Ikarovec, a gene therapy company tackling chronic eye diseases like geographic atrophy and age-related macular degeneration. Katie shares Ikarovec’s incredible journey—from starting out in the middle of a pandemic to securing a £5 million funding extension—and how a small, tight-knit team made it all happen. Katie tells us all about the science behind their work, how her career has evolved (including 25 years at Oxford Biomedica), and why stepping out of your comfort zone and creating your own luck are so important. It’s a brilliant conversation full of insights into leadership, innovation, and building something great on a shoestring budget.…
ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ